: anti-TNF increase the risk of lymphomas The FDA notified healthcare professionals that the use of TNF blockers increase the risk of lymphomas and other types of tumors.
The Food and Drug Administration, the Institute of American drug control, issued a statement announcing that, following the completion of the review of the analysis on the safety of biological drugs anti-tumor necrosis factor, which are used to the treatment of various autoimmune diseases such as arthritis, psoriasis and inflammatory bowel disease, appeared to show an increased risk of lymphomas and leukemias with these drugs nei bambini e negli adolescenti.
La scheda tecnica riporta adesso un black- warning in cui si menziona il rischio di neoplasie senza menzionare specificamente la leucemia. La FDA ha richiesto un aggiornamento anhe del foglietto illustrativo in modo che i pazienti possano essere consapevolmente informati di questo rischio.
Fonte: FDA
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm175843.htm
